
Which animal germ could become the next major human disease?
In early October, health officials in Europe reported potentially chilling news: They discovered the first known human case of a disease normally found in animals.
The person, a man in his 60s, had contracted the Shamonda virus, which mainly infects livestock. The man ultimately died from brain complications related to the infection, although his pre-existing health conditions also played a role. Despite the death, health officials stressed that Shamonda is not transmitted directly between animals, but only through the bites of tiny midges. For now at least, the risk of this virus significantly harming the general public is likely minimal, they added.
Shamonda is the latest example of a zoonotic disease that can spread from animals to humans.
Often, zoonotic diseases that spread to humans cause relatively few problems. Like Shamonda, they are unable to travel very far once they have infected or even sickened someone. Other times, however, they can gain a foothold and become illnesses that we encounter regularly from then on. This may occur because the pathogen evolves to spread more easily between people or because of the expansion of disease vectors that can infect people.
The mosquito-borne Zika virus, for example, was previously only found in parts of Africa and Asia, but began causing widespread outbreaks in the Americas more than a decade ago. Although these outbreaks eventually subsided, Zika remains endemic in the Americas. More recently, the mpox virus has caused sustained outbreaks of human-to-human transmission across the world, likely aided by several factors such as viral adaptation and chains of transmission fueled by close sexual contact. It also now circulates locally in many parts of the world, including the United States.
And while there is still serious debate about the origins of the SARS-CoV-2 coronavirus and the covid-19 pandemic, many scientists believe it is also a zoonotic disease. Even if you disagree, many pandemics have followed this model, such as the 2008 swine flu pandemic that jumped from pigs to humans.
For this latest Giz Asks, we reached out to experts in zoonotic and emerging infectious diseases to get their thoughts on what the next major zoonotic threat to humans will likely be, or at least what it might look like. The following answers have been lightly edited for grammar and clarity.
Benjamin Anderson
Public health and zoonotic disease researcher and associate director of the One Health Center of Excellence at the University of Florida.
If the question is which animal pathogen is most likely to cause the next major human disease event, my answer is the avian flu virus. If the question is which microbial threat is most likely to have the greatest impact on human health in the coming decades, antimicrobial-resistant bacterial infections deserve equal, if not greater, attention.
One of the challenges of predicting disease emergence is that we often focus on identifying a specific pathogen (germ) rather than the biological characteristics that allow microbes to succeed in humans. From this point of view, avian influenza viruses remain of particular concern. Avian influenza viruses are associated with every major influenza pandemic in history and possess an unusual capacity for evolutionary change. Influenza A viruses circulate in a large reservoir of wild birds and can infect a variety of other animal hosts, creating opportunities for adaptation and genetic reassortment. This ability to swap genetic segments and generate new viral combinations is one reason why influenza viruses have repeatedly emerged as global threats to public health.
Influenza also benefits from being a respiratory pathogen. Respiratory viruses have an inherent transmission advantage because they can spread through close contact, respiratory droplets, and in some circumstances, airborne transmission. Once a pathogen becomes effective in its person-to-person respiratory spread, population-level control becomes considerably more difficult.
At the same time, not every major health threat comes in the form of a pandemic. Antimicrobial resistance already causes a significant burden of disease worldwide and is influenced by complex interactions between humans, animals, food production systems and the environment. In many ways, resistant bacteria represent a slow-moving and already ongoing pandemic.
The emergence of H5N1 in dairy cattle and many other mammal species has reinforced why avian influenza viruses continue to receive attention. Each infection in a new host species provides an opportunity for adaptation. Importantly, this does not mean that a pandemic is inevitable, and most contagion events never progress beyond isolated infections. But considering the combination of historical precedent, genetic flexibility, broad host range and respiratory transmission, avian flu viruses possess many of the characteristics that scientists associate with future emergence.
Ultimately, the next major human disease may not be a pathogen we are currently monitoring closely. The biggest lesson is that conditions that facilitate emergence, intensive livestock production, environmental changes, global travel, and increasingly interconnected human-animal interfaces continue to create opportunities for microbes to move to new hosts and establish themselves in new ways.
Amira Roess
Professor of Global Health and Epidemiology at George Mason University College of Public Health, Department of Global and Community Health.
We are currently witnessing a very large outbreak of Ebola. The virus is spreading rapidly, affecting several countries in sub-Saharan Africa over an area the size of the United States, and its reach is expanding. This outbreak carries a very real risk that the right set of mutations will occur and result in a more transmissible virus that could lead to a pandemic. In many ways, this is what happened with mpox, another zoonotic disease that has been spreading rapidly since 2022. Just as with mpox, we mounted an inadequate response to Ebola.
There are many other zoonotic diseases that we don’t take seriously enough, like mpox. Lassa, for example, is a country we need to watch because of its ability to cause high rates of illness and death. Outbreaks are initially linked to animal exposures, and once in humans, they spread from person to person, particularly in hospital settings. If Lassa continues to spread unchecked, it will likely mutate and cause a pandemic. The MERS coronavirus is another virus we should be worried about. Outbreaks of MERS occur from time to time, mainly in the Arabian Peninsula. The first reported human cases were in 2012 and were linked to contact with camels (bats are also involved). After initial fallout, the MERS virus spread rapidly in health care settings, and 30 to 40 percent of those infected in initial outbreaks died. Surveillance and reporting today underestimates the threat of this virus. To avoid a repeat of the covid-19 pandemic, it is imperative that the global community accelerates research into this disease and implements robust surveillance to enable us to detect early cases and quickly implement control measures.
Unfortunately, most emerging zoonotic disease threats are not being taken seriously by funding agencies, nor by public health infrastructure. In the United States, our health research and public health systems are inadequate. This is directly linked to budgetary decisions made in recent history. In 2008, while we were battling two very costly wars, we hit the Great Recession. Many local public health agencies in the United States have had no choice but to implement furloughs. This meant workers were told they would be paid for four days of work a week, and told not to come in for any longer. (Of course, many worked five days a week, weekends and evenings to do what they could to prevent disease and epidemics). At the same time, the NIH budget was barely able to keep pace with inflation, despite the critical research it had supported around the world. Many of us have benefited from NIH-funded research. Cures for hepatitis C, for example, have changed the lives of millions of Americans, and NIH-funded research is the reason we have a cure. And yet here we are witnessing a further weakening of the NIH.
Global public health infrastructure and research has historically been funded by the NIH, USAID, and the CDC (let them all rest…). None of them were perfect (what is human creation?). But they did a lot of good. Their absence leaves a void that has not yet been filled. Many emerging economies are coming together to fill it. Will we be invited back to WHO or its successor? Probably. But the damage we have done over the past two years and the goodwill we have destroyed is difficult to overcome.
We know that future pandemics will have zoonotic origins. We do not have the tools to perfectly predict when major changes will occur or when the next pandemic will break out. But history teaches us that an infectious disease that plagues one part of the world is everyone’s problem. Our collective response must include rebuilding a more resilient public health infrastructure, capable of operating independently to serve all. At the same time, we must renew efforts to build a global public health infrastructure to deal with future zoonotic disease pandemics.
Jonathan Gass
Assistant Professor in the Department of Infectious Diseases and Global Health at Tufts University School of Medicine.
I am far more concerned about the conditions we create that allow pathogens to emerge than I am about any particular pathogen. Indeed, even if many pathogens persist in animals and can be transmitted to a human, thus causing the emergence of an infectious disease in humans, the presence of these pathogens in…
Gn Health